Briefings
Take a look at the briefings we have taking place this year. If you would like to sign up to any, please do so via the form at the bottom of the page.
Brought to you by Thermo Fisher Scientific.
Wednesday January 18th 2023, 8am – 9am. (Breakfast included)
The need for standardization of cell therapy manufacturing continues to be a critical driver of technological advancement and investments. Implementation of a scalable, integratable workflow can minimize open processes and reduce manual touchpoints—ultimately reducing manufacturing failures. New innovations in closed, modular, cell therapy specific instrumentation enable the development of robust and reproducible, end-to-end manufacturing processes for commercial applications. In this symposium, industry leaders will discuss benefits that can be gained from standardizing your manufacturing process and how strategic collaborations can help streamline the transition through the commercialization pipeline.
Register your place via the form at the bottom of the page.
Brought to you by Merit.
Wednesday January 18th 2023, 8am – 9am. (Breakfast included)
- How design led, technology driven, offsite construction can deliver a biotech facility faster than stick build construction methods
- What funding solutions are available to deliver a new building to avoid capital cost expenditure
- Delivering an environmentally friendly and sustainable building where scope 1 carbon emissions are eliminated
- How city regeneration can add social value
Register your place via the form at the bottom of the page.
Brought to you by Terumo.
Wednesday January 18th 2023, 12.30pm – 1.30pm.
Cell and gene therapy is past the ad hoc era of using what has always been available. Researchers have a choice in what manufacturing technologies are best for their process, and partners with early adoption programs can help therapy developers mitigate the risk of trying something new while maximizing the reward for being first in line. In this session, enjoy lunch and hear a distinguished group of leaders discuss their experience as early adopters of new technologies and the roles these partnerships played in optimization success.
Register your place via the form at the bottom of the page.
Brought to you by Sony.
Wednesday January 18th 2023, 12.30pm – 1.30pm.
Next Cell Therapy processes should start with a cell isolation multi-parameters selection to ensure the purity, a key attribute for patient safety. The development of Clinical/GMP grade equipment in close collaboration allows to achieve perfected equipment in line with the needs of cell therapy.
Register your place via the form at the bottom of the page.
Brought to you by Cytiva.
Wednesday January 18th 2023, 5pm – 6pm.
- Challenges in LV downstream processing
- Capture performance for different anion exchangers
- Optimization of polishing with Capto Core 700
Register your place via the form at the bottom of the page.
Brought to you by Andelyn.
Wednesday January 18th 2023, 5pm – 6pm.
- Strategies for improving production and scale up
- Purification strategies for multiple serotypes
- In process analytics driving process improvement decisions
Register your place via the form at the bottom of the page.
Brought to you by Invetech.
Thursday January 19th 2023, 8am – 9am. (Breakfast included)
As cell therapy developers scale their manufacturing operations, technology choices become forefront. Selecting the right technologies to manufacture cell therapies has resourcing, cost, and efficiency implications that need to be considered
- Evaluation criteria for choosing between turnkey and custom manufacturing solutions, with particular focus on fit, function, and format
- What do manufacturing expectations look like and how do they change through process development, clinical development and scaling to meet anticipated demand post-approval
- The benefits and roadblocks to using equipment that can transition from PD to GMP
Register your place via the form at the bottom of the page.
Brought to you by FUJIFILM Irvine Scientific.
Thursday January 19th 2023, 8am – 9am. (Breakfast included)
- Common hurdles and critical considerations when selecting media for cryopreservation
- How the cryoprotectant and the process you choose can determine cell viability
- The quality attribute considerations for testing and quality controls of raw materials for cryopreservation media
- Made-to-Order and Custom Media Solutions: formulation isn’t the only thing that can be customized
- How Custom Media can help improve cell viability, quality, and cell function, from formulation to packing
Register your place via the form at the bottom of the page.
Brought to you by Miltenyi.
Thursday January 19th 2023, 12.30pm – 1.30pm.
Register your place via the form at the bottom of the page.
Brought to you by Resilience.
Thursday January 19th 2023, 12.30pm – 1.30pm.
- What is a value share-based partnership & how can it inspire long term success?
- Forging collaborations with academic institutions to propel innovation
- How platform development can maximize the chances of therapeutic success in the clinic & commercially
Register your place via the form at the bottom of the page.
Brought to you by Be the Match.
Thursday January 19th 2023, 5pm – 6pm.
- Current happenings in the industry impacting developers as they look to ramp up clinical trials
- The biggest challenges facing those working on trial design, management and oversight
- What to look for in a trusted outsourcing partner to ensure trial success and advance patient outcomes
Register your place via the form at the bottom of the page.
Brought to you by PA Consulting & Catapult.
Thursday January 19th 2023, 5pm – 6pm.
Critical to the advancement of cell and gene therapies is the digital and data infrastructure underpinning development, manufacturing and commercialization. But few organizations have been able to address these challenges, with solutions fragmented and not addressing all the stakeholders’ needs. Join this executive briefing to understand the collective barriers to seamless digital, data and systems infrastructure integration and to be part of shaping a consensus as to the way forward. The discussion will focus on challenges related (but not limited) to data quality, data flow, connection and especially challenges at the interfaces.
This is a unique opportunity to be integral in defining solutions to digital infrastructure, data and systems challenges, through a pre-competitive and collaborative environment with guided activities and discussions, in order to:
- Drive consensus, alignment and collaboration in the CGT community around critical needs – and provide you with a landscape of the challenges and how they can be addressed
- Understand the diverse needs and opportunities, from across the CGT value chain, with leaders participating from academia, industry, regulatory agencies, facility developers, equipment manufacturers, providers in the automation, healthcare and digital industries
Register your place via the form at the bottom of the page.
Brought to you by Cellgenix.
Friday January 20th 2023, 8am – 9am. (Breakfast included)
- When should you start to consider switching to GMP-grade ancillary materials?
- Why use preclinical grade reagents for preclinical research instead of RUO reagents?
- Which quality attributes are relevant for preclinical research? How to qualify ancillary materials and assess their quality and economic risks?
Register your place via the form at the bottom of the page.
